Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer (Q34979358)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer |
scientific article |
Statements
1 reference
2 references
Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer (English)
1 reference
Fazlul H Sarkar
1 reference
Shadan Ali
1 reference
Sanjeev Banerjee
1 reference
Jacqueline M Schaffert
1 reference
Bassel F El-Rayes
1 reference
Philip A Philip
1 reference
1 reference
1 reference
Identifiers
1 reference